垂体瘤立体定向放射外科治疗后新发肿瘤、颈动脉狭窄与卒中的风险:一项2254例影像随访多中心研究
这项多中心回顾性研究纳入2254例垂体神经内分泌肿瘤患者,其中暴露组1377例接受立体定向放射外科(SRS),对照组877例。中位随访显示,SRS组与对照组在15年继发颅内肿瘤、新发颈动脉狭窄或闭塞及卒中的累积概率上均无统计学显著差异,按年龄分层的Cox多因素分析亦未显示SRS增加新发卒中风险。
要点
- SRS组15年继发颅内肿瘤累积概率2.3%,对照组3.7%,两组比较P=0.6。
- SRS组15年新发颈动脉狭窄或闭塞概率0.9%,对照组2%,两组比较P=0.8。
- SRS组15年卒中概率2.6%,对照组11.1%,两组比较P<0.001;按年龄分层多因素分析SRS与卒中风险无关(HR 1.85,95%CI 0.64-5.35,P=0.26)。
核心结论
- 在本研究影像监测下,与对照组相比,SRS组未显示长期继发脑肿瘤、新发狭窄或闭塞及卒中风险增加。
研究设计与样本
- 多中心回顾性研究,纳入2254例垂体神经内分泌肿瘤(PitNET)患者,其中暴露组(SRS)1377例,对照组877例。
主要发现
- SRS组风险人年为9840.1,对照组为5266.5。
- 15年继发颅内肿瘤累积概率SRS组2.3%(95%CI 0.5%-4.1%),对照组3.7%(95%CI 0%-8.7%),P=0.6;发生率分别为每1000人年1.32和0.95。
- 按年龄分层,SRS与肿瘤发生风险无关(HR 1.59,95%CI 0.57-4.47,P=0.38)。
- 15年新发颈动脉狭窄或闭塞概率SRS组0.9%(95%CI 0.2%-1.6%),对照组2%(95%CI 0%-4.4%),P=0.8。
- 15年卒中概率SRS组2.6%(95%CI 0.6%-4.6%),对照组11.1%(95%CI 6%-15.9%),P<0.001;按年龄分层Cox多因素分析SRS与卒中风险无关(HR 1.85,95%CI 0.64-5.35,P=0.26)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: A higher risk of secondary brain tumor, carotid stenosis, and stroke has been reported after conventional sella irradiation for pituitary neuroendocrine tumors (PitNET). Stereotactic radiosurgery (SRS), which is a more focused approach, is now increasingly used instead. The aim was to assess the risk of secondary brain tumor, carotid stenosis/occlusion, and stroke after SRS. METHODS: In this multicentric retrospective study, 2254 patients with PitNET were studied, 1377 in the exposed group, and 877 in the control group. RESULTS: There were 9840.1 patient-years at risk for the SRS and 5266.5 for the control group. The 15-year cumulative probability of secondary intracranial tumor was 2.3% (95% CI: 0.5%, 4.1%) for SRS and 3.7% (95% CI: 0%, 8.7%) for the control group (P = .6), with an incidence rate of 1.32 per 1000 and 0.95 per 1000, respectively. SRS was not associated with an increased risk of tumorigenesis when stratified by age (HR: 1.59 [95% CI: 0.57, 4.47], Pp = .38). The 15-year probability of new carotid stenosis/occlusion was 0.9% (95% CI: 0.2, 1.6) in the SRS and 2% (95% CI: 0, 4.4) in the control group (P = .8). The 15-year probability of stroke was 2.6% (95% CI: 0.6%, 4.6%) in the SRS and 11.1% (95% CI: 6%, 15.9%) in the control group (P < .001). In Cox multivariate analysis stratified by age, SRS (HR 1.85 [95% CI:0.64, 5.35], P = .26) was not associated with risk of new stroke. CONCLUSIONS: No increased risk of long-term secondary brain tumor, new stenosis or occlusion, and stroke was demonstrated in the SRS group compared to the control in this study with imaging surveillance.
引用
- Dumot C, Mantziaris G, Dayawansa S, et al. Risk of new tumor, carotid stenosis, and stroke after stereotactic radiosurgery for pituitary tumor: A multicenter study of 2254 patients with imaging follow-up. Neuro Oncol. 2024. PMID: 39028740. doi:10.1093/neuonc/noae133
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。